Literature DB >> 34100766

Association Between the Digital Clock Drawing Test and Neuropsychological Test Performance: Large Community-Based Prospective Cohort (Framingham Heart Study).

Rhoda Au1,2,3,4,5, Honghuang Lin2,6, Jing Yuan7,1, David J Libon8, Cody Karjadi2, Alvin F A Ang1,2,3, Sherral Devine1,2, Sanford H Auerbach2,4.   

Abstract

BACKGROUND: The Clock Drawing Test (CDT) has been widely used in clinic for cognitive assessment. Recently, a digital Clock Drawing Text (dCDT) that is able to capture the entire sequence of clock drawing behaviors was introduced. While a variety of domain-specific features can be derived from the dCDT, it has not yet been evaluated in a large community-based population whether the features derived from the dCDT correlate with cognitive function.
OBJECTIVE: We aimed to investigate the association between dCDT features and cognitive performance across multiple domains.
METHODS: Participants from the Framingham Heart Study, a large community-based cohort with longitudinal cognitive surveillance, who did not have dementia were included. Participants were administered both the dCDT and a standard protocol of neuropsychological tests that measured a wide range of cognitive functions. A total of 105 features were derived from the dCDT, and their associations with 18 neuropsychological tests were assessed with linear regression models adjusted for age and sex. Associations between a composite score from dCDT features were also assessed for associations with each neuropsychological test and cognitive status (clinically diagnosed mild cognitive impairment compared to normal cognition).
RESULTS: The study included 2062 participants (age: mean 62, SD 13 years, 51.6% women), among whom 36 were diagnosed with mild cognitive impairment. Each neuropsychological test was associated with an average of 50 dCDT features. The composite scores derived from dCDT features were significantly associated with both neuropsychological tests and mild cognitive impairment.
CONCLUSIONS: The dCDT can potentially be used as a tool for cognitive assessment in large community-based populations. ©Jing Yuan, David J Libon, Cody Karjadi, Alvin F A Ang, Sherral Devine, Sanford H Auerbach, Rhoda Au, Honghuang Lin. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 08.06.2021.

Entities:  

Keywords:  Framingham Heart Study; association; clock drawing test; cognition; digital assessment; mild cognitive impairment; neurology; neuropsychological test; technology

Year:  2021        PMID: 34100766     DOI: 10.2196/27407

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  4 in total

1.  Daily Level Association of Physical Activity and Performance on Ecological Momentary Cognitive Tests in Free-living Environments: A Mobile Health Observational Study.

Authors:  Zvinka Z Zlatar; Laura M Campbell; Bin Tang; Spenser Gabin; Anne Heaton; Michael Higgins; Joel Swendsen; David J Moore; Raeanne C Moore
Journal:  JMIR Mhealth Uhealth       Date:  2022-01-31       Impact factor: 4.773

2.  Associations Between the Digital Clock Drawing Test and Brain Volume: Large Community-Based Prospective Cohort (Framingham Heart Study).

Authors:  Jing Yuan; Rhoda Au; Cody Karjadi; Ting Fang Ang; Sherral Devine; Sanford Auerbach; Charles DeCarli; David J Libon; Jesse Mez; Honghuang Lin
Journal:  J Med Internet Res       Date:  2022-04-15       Impact factor: 7.076

3.  Automated Evaluation of Conventional Clock-Drawing Test Using Deep Neural Network: Potential as a Mass Screening Tool to Detect Individuals With Cognitive Decline.

Authors:  Kenichiro Sato; Yoshiki Niimi; Tatsuo Mano; Atsushi Iwata; Takeshi Iwatsubo
Journal:  Front Neurol       Date:  2022-05-03       Impact factor: 4.003

4.  Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.

Authors:  Masatomo Kobayashi; Yasunori Yamada; Kaoru Shinkawa; Miyuki Nemoto; Kiyotaka Nemoto; Tetsuaki Arai
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.